JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares Capital Reinvestment Ratio
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares capital reinvestment ratio. JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) has a Capital Reinvestment Ratio of 13.41x as of December 2025, meaning it reinvests 13% of its operating cash flow ($341.55K) in capital expenditures ($4.58 Million). Check JIN MEDICAL INTERNATIONAL LTD. Ordinary (ZJYL) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (2020–2025)
Capital reinvestment ratio of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares from 2020 to 2025. This chart tracks JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's Capital Reinvestment Ratio across 5 annual periods. Also explore ZJYL shareholders equity momentum to track the company's year-over-year net asset growth rate.
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares Capital Reinvestment Ratio by Year (2020–2025)
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares capital reinvestment ratio by year from 2020 to 2025. For the full cash flow conversion analysis, see ZJYL operating cash flow.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.28x | $2.90 Million | $6.63 Million | ▲ +6125.3% |
| 2023 | 0.04x | $3.11 Million | $113.94K | ▲ +44.3% |
| 2022 | 0.03x | $1.58 Million | $40.17K | ▲ +246.3% |
| 2021 | 0.01x | $5.84 Million | $42.88K | ▼ -87.1% |
| 2020 | 0.06x | $2.50 Million | $142.32K | — |